Nifty Outlook for the Week (September 14, 2015 – September 18, 2015)
EquityPandit’s Outlook for Nifty for week (September 14, 2015 – September 18, 2015): NIFTY: CNX Nifty ended the week on positive note
Home
Page 4814
Exim Bank has provided $35 million line of credit to Guinea
A USD 35 million line of credit has been provided to Guinea by the Export-Import Bank of India (EXIM) to construct and upgrade hospitals in
Oil India has got approval to produce 1 mmscmd gas in Jaisalmar
An environmental clearance has been provided to the state run Oil India Ltd for drilling 20 wells in three blocks in Jaisalmer, Rajasthan for production
Tata Motors global sales up 1.51% in August
Tata Motors has posted a 1.51 percent hike in its global sales, including Jaguar Land Rover (JLR) vehicles, to 74,639 units in August. In August
Taxi hailing apps are the biggest potential threat to auto industry, says Mahindra
On Thursday, Anand Mahindra, the Chairman of Mahindra Group said has opined that the taxi hailing apps like Uber and Ola are the biggest threat
Ford aims to expand Chennai plant
On Thursday, the US auto major Ford Motor Co has confirmed fresh investments for expanding the capacity at its manufacturing plant in Tamil Nadu. The
FM Jaitley says, the present indirect taxation system is in a complete mess
On Thursday, the Union Finance Minister Arun Jaitely said that the present indirect taxation system is in a “complete mess”. “It is in a complete
Advice for – Friday, September 11, 2015
Last Trading Session: Exactly as predicted by EquityPandit, Indian Stock Market opened gap negative for the day. EquityPandit predicted that market would consolidate post gap
Sun Pharma aims to sell facility in Ireland
The Indian drug major Sun Pharmaceutical Industries is planning to sell a manufacturing facility in Ireland which was owned by Ranbaxy and has been acquired
Suven Life has got patents for neurodegenerative drug
Suven Life Science has got grant of one patent each in 5 nations including China and Israel, for a drug which is used in the